• 1. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 2. An atlas of endohedral Sc2S cluster fullerenes?
  Li-Hua Gan,Rui Wu,Jian-Lei Tian,Patrick W. Fowler Phys. Chem. Chem. Phys., 2017,19, 419-425
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An atom efficient route to N-aryl and N-alkyl pyrrolines by transition metal catalysis?
  Supaporn Sawadjoon,Joseph S. M. Samec Org. Biomol. Chem., 2011,9, 2548-2554
• 5. An analysis of the WTC fires using CIB correlations and simple modeling
  JGQuintiere

Research Brief on Ethyl 1H-indazole-4-carboxylate (CAS: 885279-45-8) and Its Applications in Chemical Biology and Pharmaceutical Research

Ethyl 1H-indazole-4-carboxylate (CAS: 885279-45-8) is a heterocyclic compound that has garnered significant attention in recent years due to its versatile applications in medicinal chemistry and drug discovery. Indazole derivatives, including this compound, are known for their broad pharmacological activities, such as anti-inflammatory, anticancer, and antimicrobial properties. This research brief aims to provide an overview of the latest advancements related to Ethyl 1H-indazole-4-carboxylate, focusing on its synthesis, biological activities, and potential therapeutic applications.

Recent studies have highlighted the importance of Ethyl 1H-indazole-4-carboxylate as a key intermediate in the synthesis of more complex bioactive molecules. For instance, researchers have utilized this compound to develop novel kinase inhibitors targeting cancer-related pathways. The compound's structural flexibility allows for modifications that enhance its binding affinity to specific protein targets, making it a valuable scaffold in drug design. Additionally, its role in modulating enzyme activity has been explored in the context of neurodegenerative diseases, where indazole derivatives show promise as potential therapeutics.

One of the most notable advancements in the field involves the optimization of synthetic routes for Ethyl 1H-indazole-4-carboxylate. Recent publications have reported improved yields and reduced reaction times using catalytic methods, such as palladium-catalyzed cross-coupling reactions. These advancements not only facilitate large-scale production but also enable the exploration of new derivatives with enhanced pharmacological profiles. Furthermore, computational modeling studies have provided insights into the compound's molecular interactions, aiding in the rational design of next-generation drugs.

In the context of biological evaluation, Ethyl 1H-indazole-4-carboxylate has demonstrated promising results in preclinical studies. For example, its derivatives have exhibited potent inhibitory effects on tumor cell proliferation in vitro and in vivo. Mechanistic studies suggest that these effects are mediated through the disruption of key signaling pathways, such as PI3K/AKT and MAPK. Moreover, the compound's low toxicity profile in animal models underscores its potential as a safe and effective therapeutic agent.

Despite these promising findings, challenges remain in translating Ethyl 1H-indazole-4-carboxylate-based compounds into clinical applications. Issues such as bioavailability, metabolic stability, and off-target effects need to be addressed through further research. Collaborative efforts between chemists, biologists, and pharmacologists will be essential to overcome these hurdles and unlock the full therapeutic potential of this compound.

In conclusion, Ethyl 1H-indazole-4-carboxylate (CAS: 885279-45-8) represents a promising scaffold in the development of novel therapeutics. Its diverse biological activities and synthetic versatility make it a valuable tool for researchers in chemical biology and pharmaceutical sciences. Continued exploration of its derivatives and mechanisms of action will likely yield innovative treatments for a range of diseases, from cancer to neurodegenerative disorders.

• 170487-40-8(Methyl 1h-indazole-6-carboxylate)
• 677306-38-6(1H-Indazole-4-carboxylic Acid)
• 318276-74-3(6-Cinnolinecarboxylic acid methyl ester)
• 1104070-92-9(5-Phthalazinecarboxylic acid methyl ester)
• 473416-12-5(Methyl 1H-Indazole-5-carboxylate)
• 192944-51-7(Ethyl 1H-indazole-5-carboxylate)
• 192945-49-6(Methyl 1H-indazole-4-carboxylate)
• 107858-66-2(4-Cinnolinecarboxylic acid ethyl ester)
• 885278-74-0(Ethyl 1H-indazole-7-carboxylate)
• 713-09-7(Ethyl 1H-indazole-6-carboxylate)